We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current MGTX market cap is 285.55M. The company's latest EPS is USD -1.3212 and P/E is -3.41.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.33M | 3.54M | 5.1M | 2.04M | 697k |
| Operating Income | -31.76M | -28.79M | -32.76M | -43.75M | -46.77M |
| Net Income | -30.36M | -29.58M | -44.3M | 20.22M | -20.44M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.29M | 15.56M | 37.7M | 15.92M | 14.02M |
| Operating Income | -58.27M | -62.55M | -73.19M | -116.36M | -137.06M |
| Net Income | -54.75M | -57.99M | -79.56M | -129.62M | -84.03M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 288.14M | 310.26M | 267.19M | 326.74M | 309.24M |
| Total Liabilities | 197.92M | 186.74M | 175.31M | 188.57M | 187.5M |
| Total Equity | 90.22M | 123.53M | 91.89M | 138.18M | 121.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 323.89M | 363.7M | 320.16M | 318.24M | 326.74M |
| Total Liabilities | 133.09M | 125.14M | 134.76M | 200.5M | 188.57M |
| Total Equity | 190.8M | 238.56M | 185.4M | 117.74M | 138.18M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -37.39M | -66.4M | -90.82M | -105.37M | -36.74M |
| Investing | -8.61M | -13.58M | -17.14M | 34.03M | 27.34M |
| Financing | -1.23M | 56.72M | 56.31M | 84.02M | -1.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 20.05M | -63.97M | -10.53M | -73.1M | -105.37M |
| Investing | -9.37M | -37.02M | -61.72M | -44.96M | 34.03M |
| Financing | 148.24M | 82.73M | 1.71M | 95.2M | 84.02M |
| Market Cap | 285.55M |
| Price to Earnings Ratio | -3.41 |
| Price to Sales Ratio | 20.42 |
| Price to Cash Ratio | 2.21 |
| Price to Book Ratio | 2.07 |
| Dividend Yield | - |
| Shares Outstanding | 63.6M |
| Average Volume (1 week) | 129.41k |
| Average Volume (1 Month) | 186.25k |
| 52 Week Change | -40.84% |
| 52 Week High | 8.16 |
| 52 Week Low | 3.49 |
| Spread (Intraday) | 3.38 (43.5%) |
| Company Name | MeiraGTx Holdings PLC |
| Address |
27 hospital road grand cayman |
| Website | https://www.meiragtx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
